Literature DB >> 1730456

Hyperinsulinemia: possible role in obesity-induced hypertension.

L Landsberg1.   

Abstract

Data in support of the hypothesis that insulin-mediated sympathetic stimulation contributes to the hypertension that occurs in association with obesity are presented. The relation between insulin and the sympathetic nervous system derives from the effect of diet on sympathetic activity. Fasting suppresses but overfeeding stimulates the sympathetic nervous system. Insulin-mediated glucose metabolism within central neurons sensitive to insulin and glucose appears to be one important signal in this relation between diet and sympathetic activity. In the obese, hyperinsulinemia and hypertension track together in epidemiological studies. Evidence from a human population-based study (the Normative Aging Study) indicates that the abdominal form of obesity is associated with both hyperinsulinemia and increased urinary norepinephrine excretion. Elevations in urinary norepinephrine excretion, moreover, were highest in those with the highest fasting levels of insulin and glucose. These observations are consistent with the hypothesis that insulin-mediated sympathetic stimulation is a mechanism recruited in the obese to increase metabolic rate and restore energy balance; concomitant increases in sympathetic stimulation of the heart, vasculature, and kidney result in hypertension, which, according to this formulation, is an unfortunate by-product of the cardiovascular response to a metabolic adaptation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730456     DOI: 10.1161/01.hyp.19.1_suppl.i61

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Pathogenesis of hypertension in diabetes.

Authors:  Sameer N Stas; Fadi A El-Atat; James R Sowers
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Is there an estrogenic component in the metabolic syndrome?

Authors:  S Starcke; G Vollmer
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

3.  Adiposity-independent sympathetic activity in black men.

Authors:  Aamer Abbas; Lidia S Szczepaniak; Meryem Tuncel; Jonathan M McGavock; Beverley Huet; Paul J Fadel; Zhongyun Wang; Debbie Arbique; Ronald Victor; Wanpen Vongpatanasin
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

4.  The inhibitory effect of glucose on growth hormone secretion is lost in obesity but not in hypertension.

Authors:  P Limone; S E Oleandri; P Ajmone Catt; S Grottoli; C Frangioni; E Avogadri; M Perrin; M R Valetto; M Maccario
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

5.  Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.

Authors:  E A Dubois; K L Kam; G A Somsen; G J Boer; K de Bruin; H D Batink; M Pfaffendorf; E A van Royen; P A van Zwieten
Journal:  Eur J Nucl Med       Date:  1996-08

6.  Perirenal Fat and Association With Metabolic Risk Factors: The Uberlândia Heart Study.

Authors:  Leonardo Roever; Elmiro S Resende; Fernando C Veloso; Angélica L D Diniz; Nilson Penha-Silva; Antonio Casella-Filho; Paulo M M Dourado; Antonio C P Chagas
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.889

7.  Insulin resistance.

Authors:  Alan R Sinaiko; Sonia Caprio
Journal:  J Pediatr       Date:  2012-02-14       Impact factor: 4.406

8.  Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.

Authors:  M Maccario; S E Oleandri; E Avogadri; R Rossetto; S Grottoli; M Procopio; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

9.  Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting duct.

Authors:  Lijun Li; R Mayuri Garikepati; Susanna Tsukerman; Donald Kohan; James B Wade; Swasti Tiwari; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-28

Review 10.  Therapeutic considerations in the treatment of obesity hypertension.

Authors:  M R Wofford; M M Davis; K G Harkins; D S King; S B Wyatt; D W Jones
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 May-Jun       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.